Pierre Fabre Supercritical Fluids Division to exhibit at DDP Florida conference
Press Release | Pierre Fabre Médicament: Supercritical Fluids Division
JANUARY 08, 2015
Gaillac, France: – The SuperCritical Fluids Division of Pierre Fabre Medicament will attend next month’s 2015 Drug Delivery Partnerships (DDP) conference in Florida as an exhibitor.
The SuperCritical Fluids team at Booth 309 in the exhibition center at the Boca Raton Club will have latest details of advances by its Gaillac-based supercritical carbon dioxide specialists, Supercritical Fluids.
Recently Supercritical fluids posted details of a new process leading to significant energy savings on production of the western world’s most popular painkiller, ibuprofen.
The GMP technology platform has developped Formulcoat® coating process for taste masking and also Formulplex® enhancement of solubility and Formuldisp® for bioavailability. These processes permit the development of poorly soluble APIs and new formulation of bitterness drugs.
The PFM team will be using the DDP Conference’s patented Partnering One system to network with existing and potential partners in seek of further collaborations in manufacturing and innovation.
About Pierre Fabre Medicament
Pierre Fabre Médicament is one of France’s largest independent pharmaceutical laboratories, focusing on ethical drugs, health products and dermocosmetic products.
Headquartered at Castres in the French Midi-Pyrenees Departement, Pierre Fabre has a presence in more than 130 countries worldwide and has a combined workforce of more than 10,000 people of whom more than 3.000 work outside France.
Founded in 1962, company’s business activity is focused on research, development, manufacturing and marketing of cosmetics, prescription medicines and family health products. Almost half of sales are represented by pharmaceuticals and phytotherapy, with cosmetics representing the remainder.
Pierre Fabre is especially known for its vinca alkaloid anticancer drug Navelbine (vinorelbine).
Pierre Fabre CDMO has developed a broad range of contract services for external partners around the world. Pierre Fabre CDMO proposes a full service from development to commercial batches: contract manufacturing of APIs, Supercritical CO2 preformulation and finished products dry forms, liquid and semi-solid forms, lozenges and injectables of large and smaill molecules).
Pierre Fabre’s Supercritical Fluids division has developed specialized expertise in supercritical fluids technology for pharmaceutical applications, in particular in Drug Delivery Systems (DDS).
About DDP 2015
Drug Delivery Partnerships (DDP) is the longest running conference of its kind and is widely accepted as one of the world’s most authoritative conferences on collaboration in drug delivery.
The 2015 DDP conference will be a three-day event opening on January 28 at the Boca Raton Resort and Club in Florida. The event is expected to attract more than 2,000 attendees from across the USA and some 30 countries worldwide.
DDP is focused on discovery of innovative products, knowledge sharing on key trends, and forming collaborations.
Last year’s DDP conference introduced the highly advanced networking system, partnering ONE®, to enable participants to efficiently mine a large pool of potential partners, and pre-arrange private one-to-one meetings with nearly 400 meetings conducted in its inaugural year.
For 2015, DDP has expanded the program to include the most up-and-coming topics in drug delivery, including patient-centric approaches and regulatory considerations for combination products.
The Biopharmaceutical & Healthcare Division of the Institute for Institutional Research (IIR) organizes the event.
More information at: http://www.iirusa.com/ddp/welcome.xml
Claudine Richaud, Supercritical Fluids Division of Pierre Fabre Group
Tel: +33 (0) 5 63 81 24 50
Supplier: Pierre Fabre Médicament: Supercritical Fluids Division
Address: ZI Le Clergous, 16 rue Jean Rostand, BP 92 81603 GAILLAC, France
Tel: +33 (0) 5 63 81 24 00
Fax: +33 (0) 5 63 57 32 07